Trials / Conditions / Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia

11 registered clinical trials studyying Acute Lymphoblastic Leukaemia — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematolog NCT07155226	AstraZeneca	Phase 1 / Phase 2
Recruiting	Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial NCT06355583	Imperial College London	Phase 2
Recruiting	Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies NCT06037018	CytoCares Inc	Phase 1
Active Not Recruiting	A Multi-center Retrospective Study of INO Treating B-ALL NCT07238907	Ruijin Hospital	—
Completed	Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in NCT03593304	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 2 / Phase 3
Recruiting	Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia NCT01949129	St. Anna Kinderkrebsforschung	Phase 2 / Phase 3
Completed	Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers NCT01597219	University College, London	Phase 2
Completed	A Study for Older Adults With Acute Lymphoblastic Leukaemia NCT01616238	University College, London	Phase 2
Unknown	Osteonecroses in Pediatric Patients With ALL NCT01619124	Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu	—
Unknown	A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia NCT01272440	Aarhus University Hospital	—
Terminated	Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnose NCT01251809	medac GmbH	Phase 1 / Phase 2